Novartis Announces FDA Approval of Xolair® (omalizumab) for Chronic Idiopathic Urticaria (CIU), a Form of Chronic Hives
Source URL: https://qa1.novartis.us/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-chronic-idiopathic-urticaria-ciu-form-chronic-hives-0
List of links present in page
- https://qa1.novartis.us/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-chronic-idiopathic-urticaria-ciu-form-chronic-hives-0